Human herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi’s sarcoma

mBio

Volumn 5, Issue 5, 2014, Pages

  Knowlton, Emilee R ^a   Rappocciolo, Giovanna ^a   Piazza, Paolo ^a   Lepone, Lauren M ^a   Nadgir, Sagar V ^a   Bullotta, Arlene ^b   Berendam, Stella J ^a   Li, Jun ^b   Reinhart, Todd A ^a   Jenkins, Frank J ^a,b   Rinaldo, Charles R ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CELL CYCLE PROTEIN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VIRUS DNA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL LINEAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN HERPESVIRUS 8 INFECTION; IN VITRO STUDY; KAPOSI SARCOMA; LYMPHOCYTE FUNCTION; MALE; MEMORY CELL; MIXED INFECTION; NONHUMAN; PHENOTYPIC VARIATION; PLASMA CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; CELL LINE; CELL PROLIFERATION; CYTOLOGY; GENETICS; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8;

B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CHEMOKINES; CYTOKINES; DNA, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOGLOBULIN M; INTERLEUKIN-6; INTERLEUKIN-8; MICROARRAY ANALYSIS; SARCOMA, KAPOSI; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 84908431778     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01277-14     Document Type: Article

References (54)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http:// dx.doi.org/10.1126/science.7997879.
2. Mesri EA, Cesarman E, Boshoff C. 2010. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10:707-719. http://dx.doi.org/ 10.1038/nrc2888.
3. Gottwein E. 2012. Kaposi's sarcoma-associated herpesvirus microRNAs. Front. Microbiol. 3:165. http://dx.doi.org/10.3389/fmic.2012.00165.
4. Polizzotto MN, Uldrick TS, Hu D, Yarchoan R. 2012. Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome. Front. Microbiol. 3:73. http://dx.doi.org/10.3389/fmicb.2012.00073.
5. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719.
6. Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y. 2000. Differential viral protein expression in Kaposi's sarcomaassociated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am. J. Pathol. 156: 743-749. http://dx.doi.org/10.1016/S0002-9440(10)64940-1.
7. Grundhoff A, Ganem D. 2004. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113:124 -136. http://dx.doi.org/ 10.1172/JCI200417803.
8. Knowlton ER, Lepone LM, Li J, Rappocciolo G, Jenkins FJ, Rinaldo CR. 2012. Professional antigen presenting cells in human herpesvirus 8 infection. Front. Immunol. 3:427. http://dx.doi.org/10.3389/fimmu.2012.00427.
9. Uldrick TS, Polizzotto MN, Yarchoan R. 2012. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Curr. Opin. Oncol. 24:495-505. http://dx.doi.org/10.1097/CCO.0b013e328355e0f3.
10. Rappocciolo G, Hensler HR, Jais M, Reinhart TA, Pegu A, Jenkins FJ, Rinaldo CR. 2008. Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J. Virol. 82: 4793-4806. http://dx.doi.org/10.1128/JVI.01587-07.
11. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC. 1993. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150:3671-3680.
12. Nadgir SV, Hensler HR, Knowlton ER, Rinaldo CR, Rappocciolo G, Jenkins FJ. 2013. Fifty percent tissue culture infective dose assay for determining the titer of infectious human herpesvirus 8. J. Clin. Microbiol. 51:1931-1934. http://dx.doi.org/10.1128/JCM.00761-13.
13. Chan SR, Chandran B. 2000. Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains. J. Virol. 74:10920 -10929. http:// dx.doi.org/10.1128/JVI.74.23.10920-10929.2000.
14. Zhu L, Puri V, Chandran B. 1999. Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies. Virology 262:237-249. http://dx.doi.org/10.1006/viro.1999.9900.
15. Wang FZ, Akula SM, Pramod NP, Zeng L, Chandran B. 2001. Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J. Virol. 75:7517-7527. http://dx.doi.org/ 10.1128/JVI.75.16.7517-7527.2001.
16. Subramanian R, Sehgal I, D'Auvergne O, Kousoulas KG. 2010. Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells. J. Virol. 84:1704-1714. http://dx.doi.org/ 10.1128/JVI.01889-09.
17. Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I. 2012. Advances in human B cell phenotypic profiling. Front. Immunol. 3:302. http:// dx.doi.org/10.3389/fimmu.2012.00302.
18. Jackson SM, Wilson PC, James JA, Capra JD. 2008. Human B cell subsets. Adv. Immunol. 98:151-224. http://dx.doi.org/10.1016/S0065 -2776(08)00405-7.
19. Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, Chang Y. 1996. Kaposi's sarcoma- associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 10:175-180. http://dx.doi.org/10.1097/00002030-199602000-00007.
20. Jacobson LP, Jenkins FJ, Springer G, Munoz A, Shah KV, Phair J, Zhang Z, Armenian H, et al. 2000. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J. Infect. Dis. 181:1940 -1949. http:// dx.doi.org/10.1086/315503.
21. Della Bella S, Taddeo A, Colombo E, Brambilla L, Bellinvia M, Pregliasco F, Cappelletti M, Calabrò ML, Villa ML. 2010. Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment. PLoS One 5:e15029. http://dx.doi.org/ 10.1371/journal.pone.0015029.
22. Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ. 2003. Detection and quantification of Kaposi's sarcomaassociated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 17:1847-1851. http://dx.doi.org/10.1097/00002030-200308150-00015.
23. Boivin G, Côté S, Cloutier N, Abed Y, Maguigad M, Routy JP. 2002. Quantification ofhumanherpesvirus 8 by real-timePCRin blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease. J. Med. Virol. 68:399-403. http://dx.doi.org/10.1002/jmv.10217.
24. Martró E, Cannon MJ, Dollard SC, Spira TJ, Laney AS, Ou CY, Pellett PE. 2004. Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection. J. Virol. 78: 11707-11714. http://dx.doi.org/10.1128/JVI.78.21.11707-11714.2004.
25. Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, Wooster R, Kellam P. 2003. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc. Natl. Acad. Sci. U. S. A. 100:10399 -10404. http://dx.doi.org/10.1073/ pnas.1630810100.
26. Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla- Favera R, Carbone A. 2003. Gene expression profile analysis of AIDSrelated primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101:4115- 4121. http://dx.doi.org/10.1182/blood-2002-10-3090.
27. Yu F, Feng J, Harada JN, Chanda SK, Kenney SC, Sun R. 2007. B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett. 581:3485-3488. http:// dx.doi.org/10.1016/j.febslet.2007.06.056.
28. Moir S, Fauci AS. 2009. B cells in HIV infection and disease. Nat. Rev. Immunol. 9:235-245. http://dx.doi.org/10.1038/nri2524.
29. Hassman LM, Ellison TJ, Kedes DH. 2011. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J. Clin. Invest. 121:752-768. http://dx.doi.org/10.1172/JCI44185.
30. Boivin G, Gaudreau A, Routy JP. 2000. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy. AIDS 14:1907-1910. http://dx.doi.org/10.1097/00002030-200009080-00004.
31. Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA. 2002. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16:745-754. http://dx.doi.org/10.1016/ S1074-7613(02)00318-7.
32. Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, Weber M, Byland R, Bernasconi M, Berger C, Tugizov S, Speck RF, Nadal D. 2010. _1 integrin expression increases susceptibility of memory B cells to Epstein- Barr virus infection. J. Virol. 84:6667-6677. http://dx.doi.org/10.1128/ JVI.02675-09.
33. Hensler HR, Rappocciolo G, Rinaldo CR, Jenkins FJ. 2009. Cytokine production by human herpesvirus 8-infected dendritic cells. J. Gen. Virol. 90:79-83. http://dx.doi.org/10.1099/vir.0.006239-0.
34. West JA, Gregory SM, Sivaraman V, Su L, Damania B. 2011. Activation of plasmacytoid dendritic cells by Kaposi's sarcoma-associated herpesvirus. J. Virol. 85:895-904. http://dx.doi.org/10.1128/JVI.01007-10.
35. Santarelli R, Gonnella R, Di Giovenale G, Cuomo L, Capobianchi A, Granato M, Gentile G, Faggioni A, Cirone M. 2014. STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells. Sci. Rep. 4:4241. http://dx.doi.org/10.1038/srep04241.
36. Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A. 2007. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178:6092-6099. http://dx.doi.org/10.4049/jimmunol.178.10.6092.
37. Agrawal S, Gupta S. 2011. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J. Clin. Immunol. 31:89-98. http://dx.doi.org/10.1007/s10875-010-9456-8.
38. Kim CH, Pelus LM, White JR, Applebaum E, Johanson K, Broxmeyer HE. 1998. CK beta-11/macrophage inflammatory protein-3 beta/EBI1- ligand chemokine is an efficacious chemoattractant for T and B cells. J. Immunol. 160:2418-2424.
39. Teague RM, Harlan LM, Benedict SH, Chan MA. 2004. MIP-1alpha induces differential MAP kinase activation and I_B gene expression in human B lymphocytes. J. Interferon Cytokine Res. 24:403-410. http:// dx.doi.org/10.1089/1079990041535656.
40. Schulte KM, Talat N. 2010. Castleman's disease: a two compartment model of HHV8 infection. Nat. Rev. Clin. Oncol. 7:533-543. http:// dx.doi.org/10.1038/nrclinonc.2010.103.
41. Miles SA, Rezai AR, Salazar-González JF, Vander Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martfnez-Maza O. 1990. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 87:4068-4072. http://dx.doi.org/10.1073/pnas.87.11.4068.
42. Dourado I, Martínez-Maza O, Kishimoto T, Suzuki H, Detels R. 1997. Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study. AIDS Res. Hum. Retroviruses 13:781-788. http://dx.doi.org/10.1089/aid.1997.13.781.
43. Choi YB, Nicholas J. 2010. Induction of angiogenic chemokine CCL2 by human herpesvirus 8 chemokine receptor. Virology 397:369-378. http:// dx.doi.org/10.1016/j.virol.2009.11.024.
44. Xu Y, Ganem D. 2007. Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J. Gen. Virol. 88:46-50. http://dx.doi.org/10.1099/vir.0.82375-0.
45. Bottero V, Sharma-Walia N, Kerur N, Paul AG, Sadagopan S, Cannon M, Chandran B. 2009. Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression. Virology 392:34-51. http://dx.doi.org/10.1016/j.virol.2009.07.002.
46. Wang FZ, Akula SM, Sharma-Walia N, Zeng L, Chandran B. 2003. Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence. J. Virol. 77:3131-3147. http://dx.doi.org/10.1128/ JVI.77.5.3131-3147.2003.
47. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR, Jr. 1987. The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 126: 310-318. http://dx.doi.org/10.1093/aje/126.2.310.
48. Schenker EL, Hultin LE, Bauer KD, Ferbas J, Margolick JB, Giorgi JV. 1993. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry 14:307-317. http://dx.doi.org/10.1002/cyto.990140311.
49. Cerimele F, Curreli F, Ely S, Friedman-Kien AE, Cesarman E, Flore O. 2001. Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J. Virol. 75:2435-2443. http://dx.doi.org/10.1128/JVI.75.5.2435-2443.2001.
50. Stamey FR, Patel MM, Holloway BP, Pellett PE. 2001. Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens. J. Clin. Microbiol. 39:3537-3540. http://dx.doi.org/ 10.1128/JCM.39.10.3537-3540.2001.
51. Qu L, Triulzi DJ, Rowe DT, Jenkins FJ. 2011. Detection of HHV-8 (human herpesvirus-8) genomes in induced peripheral blood mononuclear cells (PBMCs) from US blood donors. Vox Sang. 100:267-271. http://dx.doi.org/10.1111/j.1423-0410.2010.01404.x.
52. Niesters HG. 2002. Clinical virology in real time. J. Clin. Virol. Off. Publ. Pan American Society For Clinical Virology 25(Suppl 3):S3-12. http:// dx.doi.org/10.1016/S1386-6532(02)00026-4.
53. _T cells. Blood 107:4781- 4789. http:// dx.doi.org/10.1182/blood-2005-12-4818.
54. Sanghavi SK, Reinhart TA. 2005. Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J. Immunol. 175:5314 -5323. http://dx.doi.org/10.4049/jimmunol.175.8.5314.